|
|
|
|
As the pipeline of highly potent oral solid dose (HPOSD) therapies grows, regulatory expectations are evolving alongside it. Bringing these products to market requires meeting strict standards for occupational safety, containment, and quality control.
|
|
|
|
|
A forward-thinking strategy that integrates technological innovation, regulatory foresight, and a strong commitment to quality enables manufacturers to produce OSDs more efficiently while meeting global patient needs for safe, effective, high-quality medications.
|
|
|
|
|
The pathway from early clinical phases to the commercial market for these revolutionary therapeutics is not always straightforward. Examine the key offerings a reliable CDMO must provide to support your OSD on its journey to market.
|
|
|
|
|
Effective tech transfer depends on careful planning and execution across multiple dimensions — from digital infrastructure that enables seamless coordination, to robust quality systems and validated analytical methods.
|
|
|
|
|
|
Pfizer Ascoli
|
Quality, safety, regulatory compliance, and supply reliability are not simply priorities — they are the foundation of our success and the constants that will guide us through whatever challenges and opportunities the future may hold.
|
|
• Request Information
|
|
|
|
|
|
|
|
|
|
|
Pfizer Newbridge
|
Every day, we show up committed to excellence, knowing that millions of patients around the world depend on the medicines we help produce. While our reach is global, our approach is personal and hands-on.
|
|
• Request Information
|
|
|
|
|
|
|
|
|
|
|
Pfizer Freiburg
|
Patients are at the core of everything we do. Through a focus on quality, reliability, and precision, we help transform scientific breakthroughs into treatments that improve health outcomes.
|
|
• Request Information
|
|
|
|
|
|
|
|
